SteadiCare is launching soon. Join the waitlist and be first in line.

Insights

Explore emerging therapies and science-backed insights on peptides, longevity, weight-loss, hair-loss, and hormone health.

Steadicare Team — SEP 22, 2026

Microdosing GLP-1s: Benefits, Limitations, and What to Expect

Microdosing GLP-1s isn't just about side effects. Lower doses may still deliver real benefits — for your metabolism, inflammation, and more.

Steadicare Team — SEP 21, 2026

Why Is My Hair Thinning? The Most Common Causes

Hair thinning is more common than most people realize — and far more treatable. Here's what's usually behind it.

Steadicare Team — SEP 18, 2026

Beyond Weight Loss: The Expanding Benefits of GLP-1 Medications

GLP-1 medications like semaglutide and tirzepatide are proving useful far beyond weight loss — here's what the latest research shows about their effects on the heart, kidneys, liver, inflammation, and cognitive health.

Steadicare Team — SEP 17, 2026

FDA Panel Backs 6 Peptides: What It Means

In 2026, an FDA advisory committee voted to recommend seven peptides — including BPC-157, TB-500, and Epitalon — for regulated access through licensed compounding pharmacies. Here's what that means, why the FDA's role in this process is worth supporting, and what each of these peptides is actually used for.

Steadicare Team — SEP 17, 2026

B12 and Lipotropics — What's The Hype?

The real story behind B12 shots, lipo injections, and MIC injections — what's in them, who they help, and what they won't do.

Steadicare Team — SEP 17, 2026

Why Most People Regain Weight After Stopping a GLP-1 — and What to Do About It

Weight regain after stopping a GLP-1 isn't a willpower problem — it's what your biology is designed to do. Here's why it happens and how to hold on to your results.

Steadicare Team — SEP 16, 2026

NAD+: What Does It Do?

NAD+ powers your cells, supports DNA repair, and drives brain and muscle function — but levels drop significantly as you age. Learn what NAD+ is and why it matters for your health.

Steadicare Team — SEP 16, 2026

Tirzepatide vs. Semaglutide: What Does the Research Show?

Semaglutide and tirzepatide are both GLP-1 medications — but they work differently, and the research shows one consistently produces more weight loss. Here's what the studies say:

Steadicare Team — SEP 16, 2026

An Introduction to Peptide Therapy: What It Is, How It Works, and What You Should Know

Peptide therapy uses the body's own signaling molecules to target specific health goals. This article covers what peptides are, the therapies with the strongest clinical track records, how topical peptides like GHK-Cu differ from injectable forms, and why sourcing matters — including the real risks of the grey market and what safe, physician-supervised treatment looks like.

Steadicare Team — SEP 15, 2026

Are GLP-1s Right for You? Here's What the Data Says

GLP-1 medications — drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — have become some of the most talked-about treatments in medicine. But beyond the headlines, what does the research actually show? Here's an honest look at the benefits, the numbers, and the risks.